Boston Scientific Sees Q3 Adj EPS $0.80-$0.82 vs $0.83 Est; Sees Sales $5.217B-$5.318B vs $5.358B Est

Benzinga Newsdesk www.benzinga.com Neutral 71.9%

Neg 0% Neu 71.9% Pos 0%

Boston Scientific (NYSE:BSX) is looking for Q3 Adj EPS of $0.80-$0.82 vs $0.83 analyst estimate. sees sales of $5.217 billion-$5.318 billion vs $5.358 billion analyst estimate.